TriSalus Life Sciences (TLSI)
NASDAQ:TLSI
US Market
Holding TLSI?
Track your performance easily

TriSalus Life Sciences (TLSI) Income Statement

24 Followers

TriSalus Life Sciences Income Statement

Last quarter (Q2 2024), TriSalus Life Sciences's total revenue was $7.36M, an increase of Infinity% from the same quarter last year. In Q2, TriSalus Life Sciences's net income was $-5.13M. See TriSalus Life Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 32.33M$ 18.51M-$ 0.00$ 0.00
Cost of Revenue
$ 4.49M$ 2.60M---
Gross Profit
$ 27.84M$ 15.91M---
Operating Expense
$ 99.58M$ 70.06M$ 2.75M$ 3.04M$ 631.35K
Operating Income
$ -71.74M$ -54.15M$ -2.75M$ -3.04M$ -631.35K
Net Non Operating Interest Income Expense
$ -645.37K$ 415.00K$ 3.02M$ 64.00K$ 3.30K
Other Income Expense
$ -7.57M$ -5.29M$ -5.84M$ 7.74M$ -83.33K
Pretax Income
$ -75.20M$ -59.03M$ 6.11M$ 4.77M$ -711.39K
Tax Provision
$ -50.84K$ 9.00K$ 570.85K--
Earnings From Equity Interest Net Of Tax
-----
Net Income Common Stockholders
$ -71.75M$ -63.28M$ 5.54M$ 4.77M$ -711.39K
Basic EPS
$ -6.72$ -6.73$ 0.38$ 0.15$ -0.09
Diluted EPS
$ -6.72$ -6.73$ 0.38$ 0.15$ -0.09
Basic Average Shares
$ 68.54M$ 9.40M$ 29.61M$ 31.25M$ 31.25M
Diluted Average Shares
$ 68.54M$ 9.40M$ 29.61M$ 31.25M$ 31.25M
Dividend Per Share
-----
Total Operating Income As Reported
-----
Reported Normalized Basic E P S
-----
Reported Normalized Diluted E P S
-----
Rent Expense Supplemental
-----
Total Expenses
$ 104.07M$ 72.66M$ 2.75M$ 3.04M$ 631.35K
Net Income From Continuing And Discontinued Operation
$ -65.91M$ -59.04M$ 5.54M$ 4.77M$ -711.39K
Normalized Income
$ -131.59M$ -53.71M$ 44.83M$ -2.98M$ -628.06K
Interest Expense
-----
EBIT
$ -74.30M$ -59.01M$ 6.11M$ -3.04M$ -631.35K
EBITDA
$ -72.65M$ -58.31M$ 6.11M$ -3.04M$ -631.35K
Currency in USD

TriSalus Life Sciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis